Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hydrocortisone cypionate is a synthetic glucocorticoid corticosteroid and a corticosteroid ester. It is the water-insoluble cypionate ester of hydrocortisone and is used primarily for its anti-inflammatory and immunosuppressive properties. When administered orally or topically in equimolar doses to hydrocortisone free alcohol (the parent compound), it exhibits equivalent biological activity. Its mechanism of action involves binding to the glucocorticoid receptor and modulating gene expression to inhibit inflammatory pathways such as phospholipase A2 and NF-kappa B while promoting anti-inflammatory genes like interleukin‑10. Clinically it is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses as well as certain endocrine disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hydrocortisone cypionate.